Desmoteplase
id:
desmoteplase-288-17305924
title:
Desmoteplase
text:
Desmoteplase is a novel, highly fibrin-specific "clot-busting" (thrombolytic) drug in development that reached phase III clinical trials. The Danish pharmaceutical company, Lundbeck, owns the worldwide rights to Desmoteplase. In 2009, two large trials were started to test it as a safe and effective treatment for patients with acute ischaemic stroke. After disappointing results in DIAS-3, DIAS-4 was terminated, and in December 2014 Lundbeck announced that they would stop the development of desmot
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Desmoteplase
date created:
date modified:
2023-08-15T16:14:51Z
main entity:
{"identifier":"Q409748","url":"https://www.wikidata.org/entity/Q409748"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/a/ab/Desmoteplase_1A5I.png","width":1218,"height":914}
fields total:
13
integrity:
15